The involvement of the release of nitric oxide in the pharmacological activity of the new furoxan derivative CHF 2363

British Journal of Pharmacology

Volumn 118, Issue 4, 1996, Pages 923-928

  Civelli, Maurizio ^a   Giossi, Massimo ^a   Caruso, Paola ^a   Razzetti, Roberta ^a   Bergamaschi, Marco ^a   Bongrani, Stefano ^a   Gasco, Alberto ^b  

^a CHIESI FARMACEUTICI S P A   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Cyclic GMP; Nitric oxide; Phenylsulphonylfuroxan; Platelet aggregation; Vasodilatation

Indexed keywords

4 ETHOXY 3 PHENYLSULPHONYLFUROXAN; ADENOSINE DIPHOSPHATE; CHF 2363; COLLAGEN; CYCLIC AMP; CYCLIC GMP; FURAZOLIDONE; GLYCERYL TRINITRATE; ISOBUTYLMETHYLXANTHINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; OXYHEMOGLOBIN; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA STRIP; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

EID: 0029780407     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15487.x     Document Type: Article

References (35)

1. AMEZCUA, J.L., DUSTING, G.J., PALMER, R.M.J. & MONCADA, S. (1988). Acetylcholine induces vasodilatation in the rabbit isolated heart through the release of nitric oxide, the endogenous nitrovasodilator. Br. J. Pharmacol., 95, 830-834.
2. BERDEAUX, A. (1993). Nitric oxide: an ubiquitous messenger. Fundam. Clin. Pharmacol., 7, 401-411.
3. BORN, G.V.R. (1962). Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature, 194, 927-929.
4. BREDT, D.S., HWANG, P.M., GLATT, C., LOWENSTEIN, C., REED, R.R. & SNYDER, S.H. (1991). Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature, 351, 714-718.
5. BREDT, D.S. & SNYDER, S.H. (1990). Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. U.S.A., 87, 682-685.
6. CIVELLI, M., CARUSO, P., GIOSSI, M., BERGAMASCHI, M., RAZZETTI, R., BONGRANI, S. & GASCO, A. (1994). CHF 2206, a new potent vasodilating and antiaggregating drug as potential nitric oxide donor. Eur. J. Pharmacol., 255, 17-24.
7. DELEAN, A., MUNSON, P.J. & RODBARD, D. (1978). Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay and physiological dose-response curves. Am. J. Physiol., 225, E97-E102.
8. FEELISCH, M. (1991). The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J. Cardiovasc. Pharmacol., 17, S25-S33.
9. FEELISCH, M. & NOACK, E. (1987). Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur. J. Pharmacol., 139, 19-30.
10. FEELISCH, M., SCHÖNAFINGER, K. & NOACK, E. (1992). Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans. Biochem. Pharmacol., 44, 1149-1157.
11. FERIOLO, R., FOLCO, G.C., FERRETTI, C., GASCO, A.M., MEDANA, C., FRUTTERO, R., CIVELLI, M. & GASCO, A. (1995). A new class of furoxan derivatives as NO donors: mechanism of action and biological activity. Br. J. Pharmacol., 114, 816-820.
12. FÖRSTER, S., WODITSCH, I., SCHRÖDER, H. & SCHRÖR, K. (1991). Reduced nitric oxide release causes nitrate tolerance in the intact coronary circulation. J. Cardiovasc. Pharmacol., 17, 867-872.
13. FURCHGOTT, R.F. (1984). The role of endothelium in the responses of vascular smooth muscle to drugs. Annu. Rev. Pharmacol. Toxicol. 24, 175-197.
14. GARTHWAITE, J. (1991). Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci., 14, 60-66.
15. GASCO, A.M., DI STILO, A., SORBA, G., GASCO, A., FERIOLI, R., FOLCO, G.C., CIVELLl, M. & CARUSO, P. (1993). 1,1-Dinitroethyl substituted furoxans: a new class of vasodilators and inhibitors of platelet aggregation. Eur. J. Med. Chem., 28, 433-438.
16. GIBSON, Q.H. & ROUGHTON, F.J.W. (1957). The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin. J. Physiol., 136, 507-526.
17. GHIGO, D., HELLER, R., CALVlNO, R., ALESSIO, P., FRUTTERO, R., GASCO. A., BOSIA, A. & PESCARMONA, G. (1992). Characterization of a new compound, S35b, as a guanylate cyclase activator in human platelets. Biochem. Pharmacol., 43, 1281-1288.
18. IGNARRO, L.J. (1989). Endothelium-derived nitric oxide: actions and properties. FASEB J., 3, 31-36.
19. IGNARRO, L.J. & KADOWITZ, P.J. (1985). Pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu. Rev. Pharmacol. Toxicol., 25, 171-191.
20. IGNARRO, L.J., LIPPTON, H., EDWARDS, J.C., BARICOS, W.H., HYMAN, A.L., KADOWITZ, P.J. & GRUETTER, C.A. (1981). Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther., 218, 739-749.
21. KEITH, R.A., BURKMAN, A.M., SOKOLOSKI, T.D. & FERTEL, R.H. (1982). Vascular tolerance to nitroglycerin and cyclic GMP generation in rat aortic smooth muscle. J. Pharmacol. Exp. Ther., 221, 525-531.
22. KOJDA, G., MEYER, W. & NOACK, E. (1993). Influence of endothelium and nitrovasodilators on free thiols and disulfides in porcine coronary smooth muscle. Eur. J. Pharmacol., 250, 385-394.
23. MARTIN, W., VILLANI, G.M., JOTHIANANDAN, D. & FURCHGOTT, R.F. (1985). Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by haemoglobin and by methylene blue in the rabbit aorta. J. Pharmacol. Exp. Ther., 232, 708-716.
24. MELLION, B.T., IGNARRO, L.J., OHLSTEIN, E.H., PONTECORVO, E.G., HYMAN, A.L. & KADOWITZ. P.J. (1981). Evidence for the inhibitory role of guanosine 3′-5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood. 57, 946-955.
25. MONCADA, S., HIGGS, E.A., HUDSON, H.F., KNOWLES, R.G., LOPEZ-JARAMILLO, P., MCCALL, T., PALMER, R.M.J., RADOMSKI, M.W., REHS, D.D. & SCHULZ, R. (1991). The L-arginine: nitric oxide pathway. J. Cardiovasc. Pharmacol., 17, S1-S9.
26. NEEDLEMAN, P. & JOHNSON, E.M. (1973). Mechanism of tolerance development to organic nitrates. J. Pharmacol. Exp. Ther., 184, 709-715.
27. PALMER, R.M.J., ASHTON, D.S. & MONCADA, S. (1988). Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 333, 664-666.
28. PALMER, R.M.J., FERRIGE, A.G. & MONCADA, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327, 524-526.
29. RADOMSKI, M.W., PALMER, R.M.J. & MONCADA, S. (1987). The antiaggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br. J. Pharmacol., 92, 639-646.
30. SALVEMINI, D., RADZISZEWSKI, W., KORBUT, R. & VANE, J. (1990). The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO-donors. Br. J. Pharmacol., 101, 991-995.
31. SCHROR, K, FÖRSTER, S. & WODITSCH, I. (1991). On-line measurement of nitric oxide release from organic nitrates in the intact coronary circulation. Naunyn-Schmied. Arch. Pharmacol., 344, 240-246.
32. SETH, P. & FUNG, H.L. (1993). Biochemical characterization of a membrane-bound enzyme responsible for generating nitric oxide from nitroglycerin in vascular smooth muscle cells. Biochem. Pharmacol., 46, 1481-1486.
33. WALDMAN, S.A., RAPOPORT, R.M., GINSBURG, R. & MURAD, F. (1986). Desensitization of nitroglycerin in vascular smooth muscle from rat and human. Biochem. Pharmacol., 35, 3525-3531.
34. YEATES, R.A. & SCHMID, M. (1992). Total prevention of the development of in vitro tolerance to organic nitrates. Experiments with antioxidants. Arznem. Forsch. Drug Res., 42, 297-302.
35. ZHANG, C,L., DE LA LANDE, I.S., STAFFORD, I. & HOROWITZ, J.D. (1994). S-nitrosothiol modulation of tolerance to glyceryl trinitrate in bovine isolated coronary artery. Eur. J. Pharmacol., 252, 299-304.